nodes	percent_of_prediction	percent_of_DWPC	metapath
Bicalutamide—CYP3A4—Temozolomide—melanoma	0.172	0.385	CbGbCtD
Bicalutamide—CYP2D6—Vemurafenib—melanoma	0.148	0.332	CbGbCtD
Bicalutamide—CYP3A4—Vemurafenib—melanoma	0.0941	0.211	CbGbCtD
Bicalutamide—CYP3A4—Docetaxel—melanoma	0.0323	0.0724	CbGbCtD
Bicalutamide—Enzalutamide—ALB—melanoma	0.00303	0.512	CrCbGaD
Bicalutamide—Enzalutamide—ABCB1—melanoma	0.00289	0.488	CrCbGaD
Bicalutamide—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00112	0.00245	CcSEcCtD
Bicalutamide—Body temperature increased—Vemurafenib—melanoma	0.00111	0.00244	CcSEcCtD
Bicalutamide—Pharyngitis—Dactinomycin—melanoma	0.00111	0.00243	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Temozolomide—melanoma	0.00111	0.00242	CcSEcCtD
Bicalutamide—Urinary tract infection—Temozolomide—melanoma	0.0011	0.0024	CcSEcCtD
Bicalutamide—Hepatic failure—Docetaxel—melanoma	0.00108	0.00237	CcSEcCtD
Bicalutamide—Chills—Bleomycin—melanoma	0.00108	0.00236	CcSEcCtD
Bicalutamide—Cardiac failure congestive—Docetaxel—melanoma	0.00107	0.00235	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Temozolomide—melanoma	0.00107	0.00233	CcSEcCtD
Bicalutamide—Alopecia—Bleomycin—melanoma	0.00106	0.00232	CcSEcCtD
Bicalutamide—Sinusitis—Temozolomide—melanoma	0.00106	0.00232	CcSEcCtD
Bicalutamide—Haemoglobin—Carmustine—melanoma	0.00105	0.00231	CcSEcCtD
Bicalutamide—Haemorrhage—Carmustine—melanoma	0.00105	0.00229	CcSEcCtD
Bicalutamide—Hot flush—Docetaxel—melanoma	0.00104	0.00228	CcSEcCtD
Bicalutamide—Hypersensitivity—Vemurafenib—melanoma	0.00104	0.00227	CcSEcCtD
Bicalutamide—Oedema peripheral—Carmustine—melanoma	0.00103	0.00226	CcSEcCtD
Bicalutamide—Menopausal symptoms—Docetaxel—melanoma	0.00103	0.00226	CcSEcCtD
Bicalutamide—Atrial fibrillation—Docetaxel—melanoma	0.00103	0.00225	CcSEcCtD
Bicalutamide—Haemoglobin—Temozolomide—melanoma	0.00102	0.00223	CcSEcCtD
Bicalutamide—Haemorrhage—Temozolomide—melanoma	0.00101	0.00222	CcSEcCtD
Bicalutamide—Asthenia—Vemurafenib—melanoma	0.00101	0.00221	CcSEcCtD
Bicalutamide—Visual impairment—Carmustine—melanoma	0.00101	0.00221	CcSEcCtD
Bicalutamide—Pharyngitis—Temozolomide—melanoma	0.00101	0.0022	CcSEcCtD
Bicalutamide—Chills—Dactinomycin—melanoma	0.001	0.0022	CcSEcCtD
Bicalutamide—Urinary tract disorder—Temozolomide—melanoma	0.001	0.00219	CcSEcCtD
Bicalutamide—Oedema peripheral—Temozolomide—melanoma	0.000998	0.00218	CcSEcCtD
Bicalutamide—Cardiac failure—Docetaxel—melanoma	0.000998	0.00218	CcSEcCtD
Bicalutamide—Pruritus—Vemurafenib—melanoma	0.000996	0.00218	CcSEcCtD
Bicalutamide—Urethral disorder—Temozolomide—melanoma	0.000993	0.00217	CcSEcCtD
Bicalutamide—Alopecia—Dactinomycin—melanoma	0.000989	0.00217	CcSEcCtD
Bicalutamide—Visual impairment—Temozolomide—melanoma	0.000976	0.00214	CcSEcCtD
Bicalutamide—Anaemia—Bleomycin—melanoma	0.000966	0.00211	CcSEcCtD
Bicalutamide—Diarrhoea—Vemurafenib—melanoma	0.000963	0.00211	CcSEcCtD
Bicalutamide—Cardiac disorder—Temozolomide—melanoma	0.00094	0.00206	CcSEcCtD
Bicalutamide—Arrhythmia—Carmustine—melanoma	0.000936	0.00205	CcSEcCtD
Bicalutamide—Dizziness—Vemurafenib—melanoma	0.000931	0.00204	CcSEcCtD
Bicalutamide—Alopecia—Carmustine—melanoma	0.000926	0.00203	CcSEcCtD
Bicalutamide—Angiopathy—Temozolomide—melanoma	0.000919	0.00201	CcSEcCtD
Bicalutamide—Mental disorder—Carmustine—melanoma	0.000918	0.00201	CcSEcCtD
Bicalutamide—Immune system disorder—Temozolomide—melanoma	0.000915	0.002	CcSEcCtD
Bicalutamide—Mediastinal disorder—Temozolomide—melanoma	0.000913	0.002	CcSEcCtD
Bicalutamide—Malnutrition—Carmustine—melanoma	0.000912	0.002	CcSEcCtD
Bicalutamide—Cough—Bleomycin—melanoma	0.000912	0.002	CcSEcCtD
Bicalutamide—Chills—Temozolomide—melanoma	0.000909	0.00199	CcSEcCtD
Bicalutamide—Dehydration—Docetaxel—melanoma	0.000905	0.00198	CcSEcCtD
Bicalutamide—Anaemia—Dactinomycin—melanoma	0.000901	0.00197	CcSEcCtD
Bicalutamide—Liver function test abnormal—Docetaxel—melanoma	0.000899	0.00197	CcSEcCtD
Bicalutamide—Vomiting—Vemurafenib—melanoma	0.000895	0.00196	CcSEcCtD
Bicalutamide—Alopecia—Temozolomide—melanoma	0.000895	0.00196	CcSEcCtD
Bicalutamide—Dry skin—Docetaxel—melanoma	0.000892	0.00195	CcSEcCtD
Bicalutamide—Myalgia—Bleomycin—melanoma	0.00089	0.00195	CcSEcCtD
Bicalutamide—Chest pain—Bleomycin—melanoma	0.00089	0.00195	CcSEcCtD
Bicalutamide—Rash—Vemurafenib—melanoma	0.000888	0.00194	CcSEcCtD
Bicalutamide—Mental disorder—Temozolomide—melanoma	0.000887	0.00194	CcSEcCtD
Bicalutamide—Dermatitis—Vemurafenib—melanoma	0.000887	0.00194	CcSEcCtD
Bicalutamide—Back pain—Carmustine—melanoma	0.000882	0.00193	CcSEcCtD
Bicalutamide—Headache—Vemurafenib—melanoma	0.000882	0.00193	CcSEcCtD
Bicalutamide—Malnutrition—Temozolomide—melanoma	0.000882	0.00193	CcSEcCtD
Bicalutamide—Breast disorder—Docetaxel—melanoma	0.00088	0.00193	CcSEcCtD
Bicalutamide—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000877	0.00192	CcSEcCtD
Bicalutamide—Confusional state—Bleomycin—melanoma	0.00086	0.00188	CcSEcCtD
Bicalutamide—Alanine aminotransferase increased—Docetaxel—melanoma	0.000859	0.00188	CcSEcCtD
Bicalutamide—Oedema—Bleomycin—melanoma	0.000853	0.00187	CcSEcCtD
Bicalutamide—Back pain—Temozolomide—melanoma	0.000853	0.00187	CcSEcCtD
Bicalutamide—Infection—Bleomycin—melanoma	0.000847	0.00185	CcSEcCtD
Bicalutamide—Anaemia—Carmustine—melanoma	0.000843	0.00185	CcSEcCtD
Bicalutamide—Dysphagia—Docetaxel—melanoma	0.000841	0.00184	CcSEcCtD
Bicalutamide—Nausea—Vemurafenib—melanoma	0.000836	0.00183	CcSEcCtD
Bicalutamide—Thrombocytopenia—Bleomycin—melanoma	0.000835	0.00183	CcSEcCtD
Bicalutamide—Myalgia—Dactinomycin—melanoma	0.00083	0.00182	CcSEcCtD
Bicalutamide—Angina pectoris—Docetaxel—melanoma	0.00082	0.00179	CcSEcCtD
Bicalutamide—Anaemia—Temozolomide—melanoma	0.000815	0.00178	CcSEcCtD
Bicalutamide—Anorexia—Bleomycin—melanoma	0.000813	0.00178	CcSEcCtD
Bicalutamide—Angioedema—Temozolomide—melanoma	0.000806	0.00176	CcSEcCtD
Bicalutamide—Oedema—Dactinomycin—melanoma	0.000795	0.00174	CcSEcCtD
Bicalutamide—Infection—Dactinomycin—melanoma	0.00079	0.00173	CcSEcCtD
Bicalutamide—Hypertension—Carmustine—melanoma	0.000788	0.00172	CcSEcCtD
Bicalutamide—Neutropenia—Docetaxel—melanoma	0.000787	0.00172	CcSEcCtD
Bicalutamide—Thrombocytopenia—Dactinomycin—melanoma	0.000779	0.0017	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.000777	0.0017	CcSEcCtD
Bicalutamide—Chest pain—Carmustine—melanoma	0.000777	0.0017	CcSEcCtD
Bicalutamide—Myalgia—Carmustine—melanoma	0.000777	0.0017	CcSEcCtD
Bicalutamide—Anxiety—Carmustine—melanoma	0.000774	0.00169	CcSEcCtD
Bicalutamide—Cough—Temozolomide—melanoma	0.000769	0.00168	CcSEcCtD
Bicalutamide—Paraesthesia—Bleomycin—melanoma	0.000766	0.00168	CcSEcCtD
Bicalutamide—Weight increased—Docetaxel—melanoma	0.000766	0.00168	CcSEcCtD
Bicalutamide—Weight decreased—Docetaxel—melanoma	0.000761	0.00167	CcSEcCtD
Bicalutamide—Hypertension—Temozolomide—melanoma	0.000761	0.00167	CcSEcCtD
Bicalutamide—Dyspnoea—Bleomycin—melanoma	0.00076	0.00166	CcSEcCtD
Bicalutamide—Anorexia—Dactinomycin—melanoma	0.000758	0.00166	CcSEcCtD
Bicalutamide—Pneumonia—Docetaxel—melanoma	0.000755	0.00165	CcSEcCtD
Bicalutamide—Confusional state—Carmustine—melanoma	0.000751	0.00164	CcSEcCtD
Bicalutamide—Myalgia—Temozolomide—melanoma	0.000751	0.00164	CcSEcCtD
Bicalutamide—Anxiety—Temozolomide—melanoma	0.000748	0.00164	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000745	0.00163	CcSEcCtD
Bicalutamide—Oedema—Carmustine—melanoma	0.000745	0.00163	CcSEcCtD
Bicalutamide—Decreased appetite—Bleomycin—melanoma	0.000741	0.00162	CcSEcCtD
Bicalutamide—Infection—Carmustine—melanoma	0.00074	0.00162	CcSEcCtD
Bicalutamide—Acute coronary syndrome—Docetaxel—melanoma	0.00074	0.00162	CcSEcCtD
Bicalutamide—Myocardial infarction—Docetaxel—melanoma	0.000735	0.00161	CcSEcCtD
Bicalutamide—Neuropathy peripheral—Docetaxel—melanoma	0.000735	0.00161	CcSEcCtD
Bicalutamide—Dry mouth—Temozolomide—melanoma	0.000734	0.00161	CcSEcCtD
Bicalutamide—Jaundice—Docetaxel—melanoma	0.000731	0.0016	CcSEcCtD
Bicalutamide—Pain—Bleomycin—melanoma	0.000729	0.0016	CcSEcCtD
Bicalutamide—Conjunctivitis—Docetaxel—melanoma	0.000729	0.0016	CcSEcCtD
Bicalutamide—Thrombocytopenia—Carmustine—melanoma	0.000729	0.0016	CcSEcCtD
Bicalutamide—Confusional state—Temozolomide—melanoma	0.000725	0.00159	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000725	0.00159	CcSEcCtD
Bicalutamide—Oedema—Temozolomide—melanoma	0.000719	0.00157	CcSEcCtD
Bicalutamide—Infection—Temozolomide—melanoma	0.000715	0.00156	CcSEcCtD
Bicalutamide—Anorexia—Carmustine—melanoma	0.00071	0.00155	CcSEcCtD
Bicalutamide—Hepatobiliary disease—Docetaxel—melanoma	0.00071	0.00155	CcSEcCtD
Bicalutamide—Epistaxis—Docetaxel—melanoma	0.000708	0.00155	CcSEcCtD
Bicalutamide—Nervous system disorder—Temozolomide—melanoma	0.000706	0.00154	CcSEcCtD
Bicalutamide—Thrombocytopenia—Temozolomide—melanoma	0.000704	0.00154	CcSEcCtD
Bicalutamide—Feeling abnormal—Bleomycin—melanoma	0.000703	0.00154	CcSEcCtD
Bicalutamide—Skin disorder—Temozolomide—melanoma	0.000699	0.00153	CcSEcCtD
Bicalutamide—Hyperhidrosis—Temozolomide—melanoma	0.000696	0.00152	CcSEcCtD
Bicalutamide—Decreased appetite—Dactinomycin—melanoma	0.000692	0.00151	CcSEcCtD
Bicalutamide—Fatigue—Dactinomycin—melanoma	0.000686	0.0015	CcSEcCtD
Bicalutamide—Anorexia—Temozolomide—melanoma	0.000686	0.0015	CcSEcCtD
Bicalutamide—Pain—Dactinomycin—melanoma	0.00068	0.00149	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Carmustine—melanoma	0.000678	0.00148	CcSEcCtD
Bicalutamide—Urticaria—Bleomycin—melanoma	0.000678	0.00148	CcSEcCtD
Bicalutamide—Haemoglobin—Docetaxel—melanoma	0.000677	0.00148	CcSEcCtD
Bicalutamide—Rhinitis—Docetaxel—melanoma	0.000675	0.00148	CcSEcCtD
Bicalutamide—Body temperature increased—Bleomycin—melanoma	0.000674	0.00148	CcSEcCtD
Bicalutamide—Haemorrhage—Docetaxel—melanoma	0.000673	0.00147	CcSEcCtD
Bicalutamide—Insomnia—Carmustine—melanoma	0.000673	0.00147	CcSEcCtD
Bicalutamide—Paraesthesia—Carmustine—melanoma	0.000669	0.00146	CcSEcCtD
Bicalutamide—Pharyngitis—Docetaxel—melanoma	0.000668	0.00146	CcSEcCtD
Bicalutamide—Urinary tract disorder—Docetaxel—melanoma	0.000665	0.00146	CcSEcCtD
Bicalutamide—Dyspnoea—Carmustine—melanoma	0.000664	0.00145	CcSEcCtD
Bicalutamide—Oedema peripheral—Docetaxel—melanoma	0.000663	0.00145	CcSEcCtD
Bicalutamide—Somnolence—Carmustine—melanoma	0.000662	0.00145	CcSEcCtD
Bicalutamide—Urethral disorder—Docetaxel—melanoma	0.00066	0.00144	CcSEcCtD
Bicalutamide—Feeling abnormal—Dactinomycin—melanoma	0.000656	0.00143	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000656	0.00143	CcSEcCtD
Bicalutamide—Insomnia—Temozolomide—melanoma	0.000651	0.00142	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Dactinomycin—melanoma	0.00065	0.00142	CcSEcCtD
Bicalutamide—Visual impairment—Docetaxel—melanoma	0.000649	0.00142	CcSEcCtD
Bicalutamide—Decreased appetite—Carmustine—melanoma	0.000647	0.00142	CcSEcCtD
Bicalutamide—Paraesthesia—Temozolomide—melanoma	0.000646	0.00141	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Carmustine—melanoma	0.000643	0.00141	CcSEcCtD
Bicalutamide—Dyspnoea—Temozolomide—melanoma	0.000641	0.0014	CcSEcCtD
Bicalutamide—Somnolence—Temozolomide—melanoma	0.00064	0.0014	CcSEcCtD
Bicalutamide—Pain—Carmustine—melanoma	0.000637	0.00139	CcSEcCtD
Bicalutamide—Constipation—Carmustine—melanoma	0.000637	0.00139	CcSEcCtD
Bicalutamide—Dyspepsia—Temozolomide—melanoma	0.000633	0.00139	CcSEcCtD
Bicalutamide—Body temperature increased—Dactinomycin—melanoma	0.000629	0.00138	CcSEcCtD
Bicalutamide—Abdominal pain—Dactinomycin—melanoma	0.000629	0.00138	CcSEcCtD
Bicalutamide—Hypersensitivity—Bleomycin—melanoma	0.000628	0.00138	CcSEcCtD
Bicalutamide—Decreased appetite—Temozolomide—melanoma	0.000625	0.00137	CcSEcCtD
Bicalutamide—Cardiac disorder—Docetaxel—melanoma	0.000625	0.00137	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Temozolomide—melanoma	0.000621	0.00136	CcSEcCtD
Bicalutamide—Fatigue—Temozolomide—melanoma	0.00062	0.00136	CcSEcCtD
Bicalutamide—Constipation—Temozolomide—melanoma	0.000615	0.00135	CcSEcCtD
Bicalutamide—Pain—Temozolomide—melanoma	0.000615	0.00135	CcSEcCtD
Bicalutamide—Feeling abnormal—Carmustine—melanoma	0.000614	0.00134	CcSEcCtD
Bicalutamide—Asthenia—Bleomycin—melanoma	0.000612	0.00134	CcSEcCtD
Bicalutamide—Angiopathy—Docetaxel—melanoma	0.000611	0.00134	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Carmustine—melanoma	0.000609	0.00133	CcSEcCtD
Bicalutamide—Immune system disorder—Docetaxel—melanoma	0.000608	0.00133	CcSEcCtD
Bicalutamide—Mediastinal disorder—Docetaxel—melanoma	0.000607	0.00133	CcSEcCtD
Bicalutamide—Chills—Docetaxel—melanoma	0.000604	0.00132	CcSEcCtD
Bicalutamide—Pruritus—Bleomycin—melanoma	0.000603	0.00132	CcSEcCtD
Bicalutamide—Arrhythmia—Docetaxel—melanoma	0.000602	0.00132	CcSEcCtD
Bicalutamide—Alopecia—Docetaxel—melanoma	0.000595	0.0013	CcSEcCtD
Bicalutamide—Feeling abnormal—Temozolomide—melanoma	0.000593	0.0013	CcSEcCtD
Bicalutamide—Mental disorder—Docetaxel—melanoma	0.00059	0.00129	CcSEcCtD
Bicalutamide—Body temperature increased—Carmustine—melanoma	0.000589	0.00129	CcSEcCtD
Bicalutamide—Abdominal pain—Carmustine—melanoma	0.000589	0.00129	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Temozolomide—melanoma	0.000588	0.00129	CcSEcCtD
Bicalutamide—Malnutrition—Docetaxel—melanoma	0.000586	0.00128	CcSEcCtD
Bicalutamide—Hypersensitivity—Dactinomycin—melanoma	0.000586	0.00128	CcSEcCtD
Bicalutamide—Urticaria—Temozolomide—melanoma	0.000572	0.00125	CcSEcCtD
Bicalutamide—Asthenia—Dactinomycin—melanoma	0.000571	0.00125	CcSEcCtD
Bicalutamide—Body temperature increased—Temozolomide—melanoma	0.000569	0.00124	CcSEcCtD
Bicalutamide—Abdominal pain—Temozolomide—melanoma	0.000569	0.00124	CcSEcCtD
Bicalutamide—Back pain—Docetaxel—melanoma	0.000567	0.00124	CcSEcCtD
Bicalutamide—Muscle spasms—Docetaxel—melanoma	0.000564	0.00123	CcSEcCtD
Bicalutamide—Hypersensitivity—Carmustine—melanoma	0.000549	0.0012	CcSEcCtD
Bicalutamide—Diarrhoea—Dactinomycin—melanoma	0.000544	0.00119	CcSEcCtD
Bicalutamide—Vomiting—Bleomycin—melanoma	0.000542	0.00119	CcSEcCtD
Bicalutamide—Anaemia—Docetaxel—melanoma	0.000542	0.00119	CcSEcCtD
Bicalutamide—Rash—Bleomycin—melanoma	0.000538	0.00118	CcSEcCtD
Bicalutamide—Dermatitis—Bleomycin—melanoma	0.000537	0.00118	CcSEcCtD
Bicalutamide—Asthenia—Carmustine—melanoma	0.000534	0.00117	CcSEcCtD
Bicalutamide—Hypersensitivity—Temozolomide—melanoma	0.00053	0.00116	CcSEcCtD
Bicalutamide—Syncope—Docetaxel—melanoma	0.000526	0.00115	CcSEcCtD
Bicalutamide—Asthenia—Temozolomide—melanoma	0.000516	0.00113	CcSEcCtD
Bicalutamide—Loss of consciousness—Docetaxel—melanoma	0.000515	0.00113	CcSEcCtD
Bicalutamide—Cough—Docetaxel—melanoma	0.000512	0.00112	CcSEcCtD
Bicalutamide—Diarrhoea—Carmustine—melanoma	0.000509	0.00111	CcSEcCtD
Bicalutamide—Pruritus—Temozolomide—melanoma	0.000509	0.00111	CcSEcCtD
Bicalutamide—Nausea—Bleomycin—melanoma	0.000507	0.00111	CcSEcCtD
Bicalutamide—Hypertension—Docetaxel—melanoma	0.000506	0.00111	CcSEcCtD
Bicalutamide—Vomiting—Dactinomycin—melanoma	0.000506	0.00111	CcSEcCtD
Bicalutamide—Rash—Dactinomycin—melanoma	0.000502	0.0011	CcSEcCtD
Bicalutamide—Chest pain—Docetaxel—melanoma	0.000499	0.00109	CcSEcCtD
Bicalutamide—Myalgia—Docetaxel—melanoma	0.000499	0.00109	CcSEcCtD
Bicalutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000496	0.00108	CcSEcCtD
Bicalutamide—Dizziness—Carmustine—melanoma	0.000492	0.00108	CcSEcCtD
Bicalutamide—Diarrhoea—Temozolomide—melanoma	0.000492	0.00108	CcSEcCtD
Bicalutamide—Dry mouth—Docetaxel—melanoma	0.000488	0.00107	CcSEcCtD
Bicalutamide—Confusional state—Docetaxel—melanoma	0.000482	0.00106	CcSEcCtD
Bicalutamide—Oedema—Docetaxel—melanoma	0.000478	0.00105	CcSEcCtD
Bicalutamide—Dizziness—Temozolomide—melanoma	0.000476	0.00104	CcSEcCtD
Bicalutamide—Infection—Docetaxel—melanoma	0.000475	0.00104	CcSEcCtD
Bicalutamide—Vomiting—Carmustine—melanoma	0.000473	0.00104	CcSEcCtD
Bicalutamide—Nausea—Dactinomycin—melanoma	0.000473	0.00103	CcSEcCtD
Bicalutamide—Shock—Docetaxel—melanoma	0.000471	0.00103	CcSEcCtD
Bicalutamide—Rash—Carmustine—melanoma	0.000469	0.00103	CcSEcCtD
Bicalutamide—Nervous system disorder—Docetaxel—melanoma	0.000469	0.00103	CcSEcCtD
Bicalutamide—Dermatitis—Carmustine—melanoma	0.000469	0.00103	CcSEcCtD
Bicalutamide—Thrombocytopenia—Docetaxel—melanoma	0.000468	0.00103	CcSEcCtD
Bicalutamide—Headache—Carmustine—melanoma	0.000466	0.00102	CcSEcCtD
Bicalutamide—Skin disorder—Docetaxel—melanoma	0.000465	0.00102	CcSEcCtD
Bicalutamide—Vomiting—Temozolomide—melanoma	0.000457	0.001	CcSEcCtD
Bicalutamide—Anorexia—Docetaxel—melanoma	0.000456	0.000998	CcSEcCtD
Bicalutamide—Rash—Temozolomide—melanoma	0.000454	0.000993	CcSEcCtD
Bicalutamide—Dermatitis—Temozolomide—melanoma	0.000453	0.000992	CcSEcCtD
Bicalutamide—Headache—Temozolomide—melanoma	0.000451	0.000986	CcSEcCtD
Bicalutamide—Nausea—Carmustine—melanoma	0.000442	0.000968	CcSEcCtD
Bicalutamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000436	0.000954	CcSEcCtD
Bicalutamide—Insomnia—Docetaxel—melanoma	0.000433	0.000947	CcSEcCtD
Bicalutamide—Paraesthesia—Docetaxel—melanoma	0.00043	0.00094	CcSEcCtD
Bicalutamide—Nausea—Temozolomide—melanoma	0.000427	0.000935	CcSEcCtD
Bicalutamide—Dyspnoea—Docetaxel—melanoma	0.000427	0.000934	CcSEcCtD
Bicalutamide—Somnolence—Docetaxel—melanoma	0.000425	0.000931	CcSEcCtD
Bicalutamide—Dyspepsia—Docetaxel—melanoma	0.000421	0.000922	CcSEcCtD
Bicalutamide—Decreased appetite—Docetaxel—melanoma	0.000416	0.00091	CcSEcCtD
Bicalutamide—Gastrointestinal disorder—Docetaxel—melanoma	0.000413	0.000904	CcSEcCtD
Bicalutamide—Fatigue—Docetaxel—melanoma	0.000413	0.000903	CcSEcCtD
Bicalutamide—Pain—Docetaxel—melanoma	0.000409	0.000895	CcSEcCtD
Bicalutamide—Constipation—Docetaxel—melanoma	0.000409	0.000895	CcSEcCtD
Bicalutamide—Feeling abnormal—Docetaxel—melanoma	0.000394	0.000863	CcSEcCtD
Bicalutamide—Gastrointestinal pain—Docetaxel—melanoma	0.000391	0.000856	CcSEcCtD
Bicalutamide—Abdominal pain—Docetaxel—melanoma	0.000378	0.000828	CcSEcCtD
Bicalutamide—Body temperature increased—Docetaxel—melanoma	0.000378	0.000828	CcSEcCtD
Bicalutamide—Hypersensitivity—Docetaxel—melanoma	0.000353	0.000771	CcSEcCtD
Bicalutamide—Asthenia—Docetaxel—melanoma	0.000343	0.000751	CcSEcCtD
Bicalutamide—Pruritus—Docetaxel—melanoma	0.000339	0.000741	CcSEcCtD
Bicalutamide—Diarrhoea—Docetaxel—melanoma	0.000327	0.000716	CcSEcCtD
Bicalutamide—Dizziness—Docetaxel—melanoma	0.000316	0.000692	CcSEcCtD
Bicalutamide—Vomiting—Docetaxel—melanoma	0.000304	0.000666	CcSEcCtD
Bicalutamide—Rash—Docetaxel—melanoma	0.000302	0.00066	CcSEcCtD
Bicalutamide—Dermatitis—Docetaxel—melanoma	0.000301	0.00066	CcSEcCtD
Bicalutamide—Headache—Docetaxel—melanoma	0.0003	0.000656	CcSEcCtD
Bicalutamide—Nausea—Docetaxel—melanoma	0.000284	0.000622	CcSEcCtD
Bicalutamide—CYP2C9—Arachidonic acid metabolism—PTGS2—melanoma	0.000131	0.00144	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	0.000131	0.00144	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—CYP17A1—melanoma	0.00013	0.00143	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP17A1—melanoma	0.000129	0.00142	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CASP3—melanoma	0.000129	0.00142	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CCND1—melanoma	0.000129	0.00142	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP17A1—melanoma	0.000128	0.00141	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—melanoma	0.000127	0.0014	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP17A1—melanoma	0.000127	0.0014	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	0.000124	0.00137	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—PTEN—melanoma	0.000124	0.00137	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—CTNNB1—melanoma	0.000124	0.00137	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—NFKB1—melanoma	0.000124	0.00136	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	0.000122	0.00135	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	0.000121	0.00133	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—NFKB1—melanoma	0.00012	0.00132	CbGpPWpGaD
Bicalutamide—CYP2C19—Biological oxidations—CYP1B1—melanoma	0.000119	0.00131	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	0.000118	0.0013	CbGpPWpGaD
Bicalutamide—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—melanoma	0.000118	0.0013	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—RPS3—melanoma	0.000117	0.00129	CbGpPWpGaD
Bicalutamide—CYP2C19—Metapathway biotransformation—CYP1B1—melanoma	0.000117	0.00129	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SKI—melanoma	0.000115	0.00127	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—SNRPE—melanoma	0.000115	0.00127	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—VEGFA—melanoma	0.000112	0.00123	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	0.000112	0.00123	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—CDKN2B—melanoma	0.00011	0.00121	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	0.00011	0.0012	CbGpPWpGaD
Bicalutamide—CYP2D6—Biological oxidations—CYP1B1—melanoma	0.000109	0.0012	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—VEGFA—melanoma	0.000109	0.0012	CbGpPWpGaD
Bicalutamide—AR—Androgen receptor signaling pathway—AKT1—melanoma	0.000109	0.0012	CbGpPWpGaD
Bicalutamide—CYP2C9—Biological oxidations—CYP1B1—melanoma	0.000108	0.00119	CbGpPWpGaD
Bicalutamide—CYP2D6—Metapathway biotransformation—CYP1B1—melanoma	0.000108	0.00119	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	0.000108	0.00119	CbGpPWpGaD
Bicalutamide—CYP2C9—Metapathway biotransformation—CYP1B1—melanoma	0.000107	0.00118	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—VDR—melanoma	0.000107	0.00118	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	0.000107	0.00117	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	0.000106	0.00116	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—MYC—melanoma	0.000103	0.00114	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	0.000103	0.00113	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	0.000103	0.00113	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	0.000102	0.00113	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—MAPK1—melanoma	0.000101	0.00111	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—EGFR—melanoma	0.000101	0.00111	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—melanoma	9.83e-05	0.00108	CbGpPWpGaD
Bicalutamide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	9.6e-05	0.00106	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—KRAS—melanoma	9.54e-05	0.00105	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—TNF—melanoma	9.37e-05	0.00103	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	9.29e-05	0.00102	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NPPA—melanoma	9.03e-05	0.000994	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CUBN—melanoma	9e-05	0.00099	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	8.79e-05	0.000967	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—melanoma	8.55e-05	0.000941	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP17A1—melanoma	8.49e-05	0.000934	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—TP53—melanoma	8.47e-05	0.000932	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPAM—melanoma	8.42e-05	0.000926	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	8.38e-05	0.000921	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	8.37e-05	0.00092	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	8.36e-05	0.00092	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CUBN—melanoma	8.2e-05	0.000902	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—melanoma	7.97e-05	0.000876	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ACER3—melanoma	7.92e-05	0.000872	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	7.9e-05	0.000869	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—NOTCH1—melanoma	7.89e-05	0.000868	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPAM—melanoma	7.67e-05	0.000844	CbGpPWpGaD
Bicalutamide—AR—SIDS Susceptibility Pathways—IL6—melanoma	7.56e-05	0.000831	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—PPARG—melanoma	7.45e-05	0.00082	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ACER3—melanoma	7.29e-05	0.000802	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	7.26e-05	0.000798	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—UGT2B10—melanoma	7.25e-05	0.000797	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ACER3—melanoma	7.23e-05	0.000795	CbGpPWpGaD
Bicalutamide—AR—Integrated Breast Cancer Pathway—AKT1—melanoma	7.16e-05	0.000787	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	7.16e-05	0.000787	CbGpPWpGaD
Bicalutamide—CYP3A4—Biological oxidations—CYP1B1—melanoma	7.15e-05	0.000786	CbGpPWpGaD
Bicalutamide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	7.05e-05	0.000776	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—melanoma	7.02e-05	0.000772	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HS3ST5—melanoma	6.74e-05	0.000741	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—UGT2B10—melanoma	6.67e-05	0.000733	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—UGT2B10—melanoma	6.61e-05	0.000727	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—HDAC2—melanoma	6.6e-05	0.000727	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—melanoma	6.52e-05	0.000718	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HS3ST5—melanoma	6.2e-05	0.000682	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HS3ST5—melanoma	6.14e-05	0.000676	CbGpPWpGaD
Bicalutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	5.93e-05	0.000652	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.42e-05	0.000597	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—CDKN2B—melanoma	5.28e-05	0.00058	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—VDR—melanoma	5.15e-05	0.000566	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLCB4—melanoma	5.11e-05	0.000562	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—melanoma	5.01e-05	0.000551	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	4.95e-05	0.000544	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC6A11—melanoma	4.8e-05	0.000528	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIP4K2A—melanoma	4.8e-05	0.000528	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ACER3—melanoma	4.77e-05	0.000524	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PRKCA—melanoma	4.74e-05	0.000522	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—ERCC2—melanoma	4.71e-05	0.000518	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLCB4—melanoma	4.7e-05	0.000517	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—MTAP—melanoma	4.67e-05	0.000514	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLCB4—melanoma	4.66e-05	0.000512	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	4.57e-05	0.000503	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.56e-05	0.000502	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC6A11—melanoma	4.42e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIP4K2A—melanoma	4.42e-05	0.000486	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC6A11—melanoma	4.38e-05	0.000482	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIP4K2A—melanoma	4.38e-05	0.000482	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—UGT2B10—melanoma	4.36e-05	0.000479	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—MTAP—melanoma	4.3e-05	0.000473	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—MTAP—melanoma	4.26e-05	0.000468	CbGpPWpGaD
Bicalutamide—AR—Generic Transcription Pathway—MYC—melanoma	4.25e-05	0.000467	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PHGDH—melanoma	4.16e-05	0.000458	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—LUM—melanoma	4.16e-05	0.000458	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.16e-05	0.000458	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—HPSE—melanoma	4.08e-05	0.000449	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HS3ST5—melanoma	4.05e-05	0.000446	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CUBN—melanoma	4.01e-05	0.000441	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CSPG4—melanoma	3.87e-05	0.000426	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—BSG—melanoma	3.87e-05	0.000426	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SDHD—melanoma	3.87e-05	0.000426	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PHGDH—melanoma	3.83e-05	0.000421	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—LUM—melanoma	3.83e-05	0.000421	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—NOTCH1—melanoma	3.8e-05	0.000418	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—LUM—melanoma	3.8e-05	0.000418	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PHGDH—melanoma	3.8e-05	0.000418	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—HPSE—melanoma	3.75e-05	0.000413	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GPAM—melanoma	3.75e-05	0.000412	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—HPSE—melanoma	3.72e-05	0.000409	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CUBN—melanoma	3.69e-05	0.000405	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CUBN—melanoma	3.65e-05	0.000402	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—PPARG—melanoma	3.59e-05	0.000395	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SDHD—melanoma	3.56e-05	0.000392	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—BSG—melanoma	3.56e-05	0.000392	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CSPG4—melanoma	3.56e-05	0.000392	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SDHD—melanoma	3.53e-05	0.000388	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CSPG4—melanoma	3.53e-05	0.000388	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—BSG—melanoma	3.53e-05	0.000388	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GPAM—melanoma	3.45e-05	0.000379	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GPAM—melanoma	3.42e-05	0.000376	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PLA2G6—melanoma	3.19e-05	0.000351	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLCB4—melanoma	3.07e-05	0.000338	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PLA2G6—melanoma	2.93e-05	0.000322	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PLA2G6—melanoma	2.91e-05	0.00032	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC6A11—melanoma	2.89e-05	0.000318	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIP4K2A—melanoma	2.89e-05	0.000318	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—VCAN—melanoma	2.86e-05	0.000315	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—MTAP—melanoma	2.81e-05	0.000309	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.71e-05	0.000298	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—VCAN—melanoma	2.63e-05	0.00029	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.62e-05	0.000288	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—VCAN—melanoma	2.61e-05	0.000287	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—LUM—melanoma	2.5e-05	0.000275	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PHGDH—melanoma	2.5e-05	0.000275	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.47e-05	0.000272	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—HPSE—melanoma	2.45e-05	0.00027	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP17A1—melanoma	2.42e-05	0.000266	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CUBN—melanoma	2.41e-05	0.000265	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.38e-05	0.000262	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.38e-05	0.000262	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	2.35e-05	0.000259	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SDHD—melanoma	2.33e-05	0.000256	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—BSG—melanoma	2.33e-05	0.000256	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CSPG4—melanoma	2.33e-05	0.000256	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GNA11—melanoma	2.28e-05	0.000251	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GPAM—melanoma	2.25e-05	0.000248	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—FASN—melanoma	2.23e-05	0.000246	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP17A1—melanoma	2.22e-05	0.000244	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP17A1—melanoma	2.2e-05	0.000242	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—SLC5A5—melanoma	2.2e-05	0.000242	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.17e-05	0.000239	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	2.14e-05	0.000236	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CD44—melanoma	2.12e-05	0.000233	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—GNAQ—melanoma	2.12e-05	0.000233	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MAPK3—melanoma	2.1e-05	0.000231	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GNA11—melanoma	2.1e-05	0.000231	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GNA11—melanoma	2.08e-05	0.000229	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.08e-05	0.000228	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.06e-05	0.000226	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—FASN—melanoma	2.05e-05	0.000226	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—MYC—melanoma	2.05e-05	0.000225	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—FASN—melanoma	2.04e-05	0.000224	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—CYP1B1—melanoma	2.03e-05	0.000224	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—SLC5A5—melanoma	2.02e-05	0.000222	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—SLC5A5—melanoma	2e-05	0.00022	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—GNAQ—melanoma	1.95e-05	0.000215	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CD44—melanoma	1.95e-05	0.000215	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—GNAQ—melanoma	1.93e-05	0.000213	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CD44—melanoma	1.93e-05	0.000213	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PLA2G6—melanoma	1.92e-05	0.000211	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.89e-05	0.000208	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.88e-05	0.000206	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—CYP1B1—melanoma	1.87e-05	0.000206	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—CYP1B1—melanoma	1.85e-05	0.000204	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.79e-05	0.000197	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—VCAN—melanoma	1.72e-05	0.000189	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ABCB1—melanoma	1.67e-05	0.000184	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.64e-05	0.00018	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PRKCA—melanoma	1.54e-05	0.000169	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ABCB1—melanoma	1.54e-05	0.000169	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ERCC2—melanoma	1.53e-05	0.000168	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ABCB1—melanoma	1.53e-05	0.000168	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP17A1—melanoma	1.45e-05	0.00016	CbGpPWpGaD
Bicalutamide—AR—Gene Expression—AKT1—melanoma	1.42e-05	0.000156	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PRKCA—melanoma	1.42e-05	0.000156	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ERCC2—melanoma	1.41e-05	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PRKCA—melanoma	1.4e-05	0.000155	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ERCC2—melanoma	1.39e-05	0.000153	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GNA11—melanoma	1.37e-05	0.000151	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—FASN—melanoma	1.34e-05	0.000148	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—SLC5A5—melanoma	1.32e-05	0.000145	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—GNAQ—melanoma	1.28e-05	0.00014	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CD44—melanoma	1.28e-05	0.00014	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.27e-05	0.000139	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—CYP1B1—melanoma	1.22e-05	0.000134	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CG—melanoma	1.21e-05	0.000133	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PPARG—melanoma	1.16e-05	0.000128	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.15e-05	0.000127	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CG—melanoma	1.11e-05	0.000122	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CG—melanoma	1.1e-05	0.000121	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PPARG—melanoma	1.07e-05	0.000118	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PPARG—melanoma	1.06e-05	0.000117	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CD—melanoma	1.06e-05	0.000117	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—ALB—melanoma	1.05e-05	0.000115	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ABCB1—melanoma	1.01e-05	0.000111	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CD—melanoma	9.76e-06	0.000107	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CD—melanoma	9.67e-06	0.000106	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—ALB—melanoma	9.63e-06	0.000106	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—ALB—melanoma	9.55e-06	0.000105	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PRKCA—melanoma	9.26e-06	0.000102	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CB—melanoma	9.25e-06	0.000102	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ERCC2—melanoma	9.19e-06	0.000101	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTGS2—melanoma	9.16e-06	0.000101	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CB—melanoma	8.51e-06	9.36e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CB—melanoma	8.43e-06	9.27e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTGS2—melanoma	8.43e-06	9.27e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTGS2—melanoma	8.35e-06	9.19e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PTEN—melanoma	7.99e-06	8.79e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PTEN—melanoma	7.35e-06	8.08e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PTEN—melanoma	7.29e-06	8.01e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CG—melanoma	7.26e-06	7.98e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PPARG—melanoma	7e-06	7.7e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CD—melanoma	6.38e-06	7.02e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—ALB—melanoma	6.3e-06	6.93e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—PIK3CA—melanoma	5.64e-06	6.2e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CB—melanoma	5.56e-06	6.12e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTGS2—melanoma	5.51e-06	6.06e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—PIK3CA—melanoma	5.18e-06	5.7e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—PIK3CA—melanoma	5.14e-06	5.65e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PTEN—melanoma	4.81e-06	5.29e-05	CbGpPWpGaD
Bicalutamide—CYP2C19—Metabolism—AKT1—melanoma	4.6e-06	5.07e-05	CbGpPWpGaD
Bicalutamide—CYP2D6—Metabolism—AKT1—melanoma	4.24e-06	4.66e-05	CbGpPWpGaD
Bicalutamide—CYP2C9—Metabolism—AKT1—melanoma	4.2e-06	4.62e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—PIK3CA—melanoma	3.39e-06	3.73e-05	CbGpPWpGaD
Bicalutamide—CYP3A4—Metabolism—AKT1—melanoma	2.77e-06	3.05e-05	CbGpPWpGaD
